Bcl-2 overexpression attenuates SP600125-induced apoptosis in human leukemia U937 cells

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• SP600125 is a specific inhibitor of c-Jun N-terminal kinase (JNK).
• JNK inhibitors are known to induce apoptosis and block cell cycle progression.
• Understanding the role of antiapoptotic proteins in response to JNK inhibition is crucial.

Purpose of the Study:

• To investigate the mechanistic insights of SP600125-induced apoptosis and cell cycle arrest.
• To elucidate the role of Bcl-2 in mediating resistance to SP600125.
• To explore the effects of Bcl-2 on SP600125-induced G2/M phase arrest and endoreduplication.

Main Methods:

• Treatment of U937 cells with SP600125.
• Overexpression of antiapoptotic protein Bcl-2.
• Assessment of cell cycle progression, apoptosis markers (LDH release, DNA fragmentation, caspase-3 activation), and protein levels (cyclin B1, cdc25c, IAP-2).
• Treatment with Bcl-2 inhibitor HA14-1.

Main Results:

• SP600125 induced G2/M cell cycle arrest by decreasing cyclin B1 and cdc25c levels.
• SP600125 promoted apoptosis via caspase-3 activation and substrate degradation.
• Bcl-2 overexpression conferred resistance to SP600125-induced apoptosis but increased sensitivity to G2/M arrest and endoreduplication.
• Bcl-2 inhibited caspase-3 activation and sustained IAP-2 levels.
• HA14-1 attenuated Bcl-2's anti-apoptotic effect.

Conclusions:

• Bcl-2 plays a significant role in mediating resistance to SP600125-induced apoptosis.
• Bcl-2 overexpression promotes G2/M phase arrest and endoreduplication in response to SP600125.
• These findings provide mechanistic insights into JNK inhibitor-induced cell death and cell cycle regulation.